ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

INTS Intesity Therapeutics Inc

3,86
-0,14 (-3,50%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Intesity Therapeutics Inc INTS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,14 -3,50% 3,86 23:16:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,95 3,85 3,95 3,86 4,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/4/202414:01PRNUSIntensity Therapeutics to Participate in the LD Micro..
26/3/202413:01GLOBEPortage Biotech Completes Monetization of Intensity..
14/3/202421:09PRNUSIntensity Therapeutics Reports Full Year 2023 Financial..
14/3/202413:00PRNUSIntensity Therapeutics to Participate in the 36th Annual..
08/3/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202414:01PRNUSIntensity Therapeutics to Present at the 2024 BIO CEO &..
07/2/202422:15EDGAR2Form 8-K - Current report
03/1/202414:01PRNUSIntensity Therapeutics Provides Business Update Reflecting..
12/12/202314:02EDGAR2Form 8-K - Current report
12/12/202314:01PRNUSIntensity Therapeutics Appoints Joseph Talamo, CPA, as Chief..
08/12/202314:30PRNUSIntensity Therapeutics Presents Positive INT230-6 Data in..
01/12/202314:01PRNUSIntensity Therapeutics Selected for Spotlight Oral..
13/11/202318:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:02EDGAR2Form 8-K - Current report
13/11/202314:01PRNUSIntensity Therapeutics Reports Third Quarter Financial..
02/11/202312:01PRNUSIntensity Therapeutics Presents Positive INT230-6 Data in..
07/9/202314:01PRNUSIntensity Therapeutics Receives Orphan Drug Designation for..
05/9/202314:01PRNUSIntensity Therapeutics to Present at the H.C. Wainwright..
14/8/202313:01PRNUSIntensity Therapeutics Reports Second Quarter Financial..
07/8/202313:01PRNUSIntensity Therapeutics to Announce Financial Results for the..
10/7/202314:00PRNUSIntensity Therapeutics, Inc. Announces the Closing and Full..
05/7/202322:15PRNUSIntensity Therapeutics, Inc. Announces Closing of Upsized..
30/6/202302:00PRNUSIntensity Therapeutics, Inc. Announces Pricing of Upsized..
06/6/202313:35PRNUSIntensity Therapeutics Reports INT230-6 Can Cause Immune..
03/6/202314:00PRNUSIntensity Therapeutics' INT230-6 Prolongs Survival Alone or..

Dernières Valeurs Consultées

Delayed Upgrade Clock